Evidence map›Paper›PMID 26607175›Full record

ArticleStem cells translational medicine2016

Human Periodontal Stem Cells Release Specialized Proresolving Mediators and Carry Immunomodulatory and Prohealing Properties Regulated by Lipoxins.

Eleonora Cianci, Antonio Recchiuti, Oriana Trubiani, Francesca Diomede, Marco Marchisio, Sebastiano Miscia, Romain A Colas, Jesmond Dalli, Charles N Serhan, Mario Romano

Abstract read
In one paragraph

Article in Stem cells translational medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. BML-111 inhibit HBMC oral health · 2024
    Article
  12. Article
  13. Article
  14. Lipoxin AFrontiers in immunology · 2024
    Article
  15. Novel lipid mediator 7Frontiers in cell and developmental biology · 2024
    Article
  16. Inflammation, lipids, and pain in vulvar disease.Pharmacology & therapeutics · 2023
    Review
  17. Article
  18. Review
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Eleonora CianciDepartment of Medicine and Aging Science, "G. D'Annunzio" University of Chieti-Pescara, Chieti, Italy StemTeCh Group, "G. D'Annunzio" University of Chieti-Pescara, Chieti, Italy Department of Medical, Oral and Biotechnological Sciences, "G. D'Annunzio" University of Chieti-Pescara, Chieti, Italy.
Antonio RecchiutiDepartment of Medical, Oral and Biotechnological Sciences, "G. D'Annunzio" University of Chieti-Pescara, Chieti, Italy.
Oriana TrubianiStemTeCh Group, "G. D'Annunzio" University of Chieti-Pescara, Chieti, Italy Department of Medical, Oral and Biotechnological Sciences, "G. D'Annunzio" University of Chieti-Pescara, Chieti, Italy.
Francesca DiomedeStemTeCh Group, "G. D'Annunzio" University of Chieti-Pescara, Chieti, Italy Department of Medical, Oral and Biotechnological Sciences, "G. D'Annunzio" University of Chieti-Pescara, Chieti, Italy.
Marco MarchisioDepartment of Medicine and Aging Science, "G. D'Annunzio" University of Chieti-Pescara, Chieti, Italy StemTeCh Group, "G. D'Annunzio" University of Chieti-Pescara, Chieti, Italy.
Sebastiano MisciaDepartment of Medicine and Aging Science, "G. D'Annunzio" University of Chieti-Pescara, Chieti, Italy StemTeCh Group, "G. D'Annunzio" University of Chieti-Pescara, Chieti, Italy.
Romain A ColasCenter for Experimental Therapeutics and Reperfusion Injury, Harvard Institutes of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Jesmond DalliCenter for Experimental Therapeutics and Reperfusion Injury, Harvard Institutes of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Charles N SerhanCenter for Experimental Therapeutics and Reperfusion Injury, Harvard Institutes of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Mario RomanoStemTeCh Group, "G. D'Annunzio" University of Chieti-Pescara, Chieti, Italy Department of Medical, Oral and Biotechnological Sciences, "G. D'Annunzio" University of Chieti-Pescara, Chieti, Italy mromano@unich.it.

Funding

Resolution Mechanisms in Acute Inflammation: Resolution PharmacologyP01GM095467 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI SERHAN, CHARLES NICHOLAS · 2011 to 2020
$14.8M
NIGMS NIH HHS GM-095467NIGMS NIH HHS P01 GM095467
6 · The paper itself

Abstract

unlabelledUnresolved inflammation and tissue destruction are underlying mechanisms of periodontitis, which is linked to dysregulated polymorphonuclear neutrophil (PMN) functions. Lipoxin A4 (LXA4) is a specialized proresolving lipid mediator (SPM) that dampens excessive inflammation, promotes resolution, and protects from leukocyte-mediated tissue damage. Human periodontal ligament stem cells (hPDLSCs) represent key players during tissue regeneration and may contribute to resolution of inflammation; thus, they may represent a promising tool in regenerative dentistry. In the present study, we investigated the actions of hPDLSCs on PMN apoptosis and antimicrobial functions, and determined the impact of LXA4 on hPDLSCs. hPDLSCs significantly reduced apoptosis and stimulated microbicidal activity of human PMNs, via both cell-cell interactions and paracrine mechanisms. Lipid mediator metabololipidomics analysis demonstrated that hPDLSCs biosynthesize SPMs, including resolvin D1, D2, D5, and D6; protectin D1; maresins; and LXB4; as well as prostaglandins D2, E2, and F2α. LXA4 significantly enhanced proliferation, migration, and wound healing capacity of hPDLSCs through the activation of its cognate receptor ALX/FPR2, expressed on hPDLSCs. Together, these results demonstrate that hPDLSCs modulate PMN functions, and provide the first evidence that stem cells generate SPM and that the LXA4-ALX/FPR2 axis regulates regenerative functions of hPDLSCs by a novel receptor-mediated mechanism. SIGNIFICANCE: These findings uncovered unappreciated features of stem cells from the periodontal ligament, supporting the notion that these cells may act as master regulators of pathophysiological events through the release of mediators that promote the resolution of inflammation and bacterial killing. The study also demonstrated that it is possible to modulate important functions of periodontal stem cells using lipoxin A4, a potent endogenous stop signal of inflammation. Thus, this study revealed an unappreciated anti-inflammatory proregenerative circuit that may be exploited to combat periodontal pathologies using resident stem cells. Moreover, the data may represent a more general template to explain the immunomodulatory functions of stem cells.

Indexed as

AdultApoptosisCell MovementCell ProliferationCells, CulturedFemaleHumansLipoxinsMaleNeutrophilsPeriodontal LigamentRegenerationStem CellsLipoxinsImmunomodulationLipid mediatorsLipoxin A4Periodontal ligament stem cellsRegeneration

Identifiers

PMID26607175
PMCPMC4704879

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.